People | 10 April 2026
Biocon appoints Mandar Ghatnekar as Chief Technology Officer
Former Global Head of IT & Digital Transformation at Biocon Biologics steps into enterprise-wide technology leadership role
Former Global Head of IT & Digital Transformation at Biocon Biologics steps into enterprise-wide technology leadership role
In his new role, he is expected to further strengthen Zenex Animal Health’s market position and accelerate its next phase of growth.
The leading hospital chain appoints Lokesh Taridalu Shivakumar as Facility Director for Yeshwanthapur hospital
Former Interim CEO takes charge to drive strategic growth, strengthen clinical excellence, and advance patient-centric oncology innovation
Veteran HR leader comes with over two decades of experience to spearhead talent strategy, leadership development, and culture transformation
In his new role, Saran will spearhead the end-to-end launch framework for innovation-led portfolio
He brings extensive cross-functional expertise built through leadership roles
With more than two decades of experience, he brings deep expertise in sales, marketing, business transformation, and strategic leadership
She brings 20 years of in vivo pharmacology experience across academia and industry, including senior scientific and leadership roles at Orion Pharma and Charles River
Kedar Upadhye has also been appointed as Chief Financial Officer of Biocon Limited
Giri stated he is stepping down to pursue new opportunities after careful consideration
Vinita has made expansion in the U.S. a core pillar of Lupin’s worldwide growth strategy
Meenal brings in more than 16 years of international experience across Europe, Asia and the Middle East
Dawson joins Roche from the Peter MacCallum Cancer Centre, where he serves as Associate Director of Research
Garijo will be the first woman to lead Sanofi in its history
Over a two-decade career, Dr. Berman has worked on more than a dozen clinical-stage immunotherapies, including senior leadership roles in developing four oncology biologics
A PhD in Pharmaceutical Sciences, Dr Singh has led global regulatory audits, product validations, and quality systems spanning therapeutic formulations, dietary supplements, and functional foods
Stevens succeeds Milton Boyer, who has stepped down as CEO but will remain closely involved with the business as an independent member of Kindeva’s Board of Directors
Berendsen brings over 15 years of financial leadership experience spanning professional services and international trade
Appointment supports AstraZeneca’s $50 billion US investment and ambition to reach $80 billion in Total Revenue by 2030
Subscribe To Our Newsletter & Stay Updated
_256_275.jpg)
